Form 4: Elanco Executive Disposes of Shares for Tax Obligations Related to RSU Vesting

Elanco Animal Health Inc.'s EVP, Manufacturing and Quality, Grace McArdle, reported a planned disposition of 4,346 common shares on July 3, 2025, to cover tax liabilities from restricted stock unit vesting.

Summary

• Grace McArdle, Executive Vice President of Manufacturing and Quality at Elanco Animal Health Inc. (ELAN), is the reporting person.
• The transaction involves the disposition of 4,346 shares of Elanco common stock.
• The transaction date is July 3, 2025.
• The shares were disposed of at a price of $14.64 per share.
• The purpose of the disposition was to cover the reporting person's tax liability upon the vesting of restricted stock units (RSUs) previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
• Following this transaction, Grace McArdle will beneficially own 76,049 shares of common stock.
• The Form 4 filing was signed on July 8, 2025.

Sentiment

Score: 5

Explanation: The transaction is a routine disposition of shares to cover tax obligations upon RSU vesting, which is a neutral event in terms of company performance or outlook.

Positives

• The transaction indicates the vesting of previously awarded restricted stock units, which is a standard component of executive compensation plans.
• The executive retains a substantial beneficial ownership of 76,049 shares of common stock after the transaction, demonstrating continued alignment with shareholder interests.

Negatives

• The transaction results in a reduction of 4,346 shares from the executive's direct beneficial ownership.

Risks

• No specific operational or financial risks are disclosed in this Form 4 filing, as it primarily reports an insider transaction for compensation-related tax purposes.

Future Outlook

N/A. This Form 4 filing reports a planned insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation and tax obligations, which is a common practice across publicly traded companies in all industries, including the animal health sector. It does not provide insights into broader industry trends or competitive dynamics.

Related Party Transactions

• The transaction involves the disposition of shares to the company to cover tax liabilities arising from RSU vesting, which is a standard compensation practice rather than a related-party transaction requiring special disclosure beyond the Form 4 itself.

Stakeholder Impact

• Shareholders: A minor reduction in the executive's direct shareholding, but indicates routine executive compensation practices and the executive's continued significant ownership.

Next Steps

• N/A. This Form 4 filing reports a planned transaction and does not outline future actions or milestones for the company or the reporting person beyond the transaction itself.

Key Dates

Keywords

Elanco, ELAN, Form 4, insider transaction, stock vesting, executive compensation, share disposition, tax withholding, Grace McArdle